17th November 2023 (12 Topics)
1
Nov
2
Nov
3
Nov
4
Nov
6
Nov
7
Nov
8
Nov
9
Nov
10
Nov
11
Nov
13
Nov
14
Nov
15
Nov
16
Nov
17
Nov
18
Nov
20
Nov
21
Nov
22
Nov
23
Nov
24
Nov
25
Nov
27
Nov
28
Nov
29
Nov
30
Nov
New technological advancements, Health and medicine
Context:
As per the latest update, the Central Drugs Standard Control Organization has been working to launch an Integrated IT platform to bring in transparency and uniformity in all its processes to create confidence in domestic and international markets.
About the New IT Portal:
- The portal will create provisions to capture information from various stakeholders routinely “similar to ITR returns and GST filing”.
- Objective:
- To track products right from the stage of procuring raw material, to supply chain, and finally patterns of consumption categorised by quantity, area, and season.
- Key features:
- The portal will enable manufacturers, distributors and retailers to upload their invoices on the portal for this end-to-end tracking to become possible.
- To share information about spurious and not of standard quality medicines with state regulators to tackle the problem of the movement of these drugs across state boundaries.
- Investigations and prosecution launches will also be done through the portal in such cases. It will also help track all types of court cases for prosecution and convictions.
- It will bring online activities that are still done physically like periodic safety updates, show cause notices, adverse event reporting and post approval changes.
- Improve inspections by assigning inspectors at random to various sites in a masked manner, randomised allocation of work such as processing applications for licenses and approvals.
- Assigning QR codes to samples collected and reports to allow verification at every stage of the process and automatically generate officials’ performance reports.
- Requirements:
- The online platform will need to be compatible with other government portals such as the Government e-Marketplace, Bureau of Indian Standards and Clinical Trial Registry.
- It will also also have a provision to sign documents using authentication mechanisms like OTP, Aadhaar, PAN card, and DigiLocker.
What was the immediate trigger point?
- To improve the regulatory framework after a series of incidents came to light where Indian manufactured syrups were found to be contaminated and were even linked to deaths of children in the Gambia and Uzbekistan.
- To make the global standard for good manufacturing practices will be made mandatory for all Indian companies.
|
Central Drugs Standard Control Organization:
|
Courses
Study
Notes
Home
Resources
More
